The role of PET-CT in the management of patients with advanced cancer of the head and neck.
The development of functional imaging using positron emission tomography (PET) has been a major advancement in clinical oncology. In addition, the integration of functional imaging with CT anatomical imaging (PET-CT) has dramatically increased the clinical applicability of PET. This review discusses the current role of PET-CT in head and neck cancer, focusing on its role in staging, detection of unknown primaries, radiotherapy planning, assessment of treatment response, and biological characterization of disease. We also demonstrate why PET-CT should be an integral part of modern management of head and neck cancer.
Corry
June
J
Division of Radiation Oncology, Peter MacCallum Cancer Centre, Locked Bag No 1, A'Beckett Street, Melbourne 8006, Australia. June.Corry@petermac.org
Rischin
Danny
D
Hicks
Rodney J
RJ
Peters
Lester J
LJ
D006258:Head and Neck Neoplasms / Q000175:diagnosis* / Q000473:pathology*; D006801:Humans; D008495:Medical Oncology / Q000379:methods*; D009367:Neoplasm Staging; D049268:Positron-Emission Tomography / Q000379:methods*; D011379:Prognosis; D019275:Radiopharmaceuticals; D011880:Radiotherapy Planning, Computer-Assisted / Q000379:methods; D014057:Tomography, X-Ray Computed / Q000379:methods*; D016896:Treatment Outcome
D019275:Radiopharmaceuticals